On this page
What each program costs in Maine
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the State of Maine Health Plan cover GLP-1s for weight loss?
Since July 1, 2026 the State of Maine Health Plan covers GLP-1s for weight loss only for members enrolled in Virta Health who get the prescription from a Virta provider. Existing users had to be enrolled with Virta by October 30, 2026 to keep coverage.
Maine Office of Employee Health, Wellness, & Workers' Compensation
The Office of Employee Health says weight-loss GLP-1 coverage requires Virta enrollment and a Virta prescriber from July 1, 2026.
“State of Maine Health Plan Members with GLP-1 prescriptions for weight loss are required to enroll in Virta Health and receive their GLP-1 prescription from a Virta provider to maintain coverage.”
https://www.maine.gov/bhr/oeh/benefits/Open_Enrollment · read Oct 29, 2026
Maine Office of Employee Health, Wellness, & Workers' Compensation
Members already on a weight-loss GLP-1 had to be enrolled with Virta by October 30, 2026.
“Health plan members and their eligible dependents with existing GLP-1 prescriptions for weight loss can begin the application/enrollment process as soon as possible, but must be actively enrolled with Virta by October 30, 2026, to ensure continuity of coverage.”
https://www.maine.gov/bhr/oeh/benefits/Open_Enrollment · read Oct 29, 2026
Does Maine Medicaid (MaineCare) cover GLP-1s for weight loss?
Not covered for weight loss
The MaineCare drug list says weight loss drugs are not covered, and it allows Wegovy for heart risk or a liver condition and Zepbound for sleep apnea, not for weight loss alone. Read from state documents Nov 6, 2026.
What Maine Medicaid (MaineCare)'s documents say about each drug for weight loss. Read Nov 6, 2026. Maine Department of Health and Human Services, Office of MaineCare Services.
WegovyNo
Covered for heart event risk reduction or a liver condition (MASH). BMI over 27, not for weight loss only.
“Wegovy: Patient has BMI > 27 kg/m2, and is not being used for weight loss only”
Maine DHHS, Office of MaineCare Services Pharmacy Unit (MaineCare PDL, Optum) · Effective Oct 9, 2026 · read Nov 6, 2026
“Weight loss drugs are not covered as permitted by Federal Medicaid regulations and Maine Medicaid (MaineCare) Policy.”
Maine DHHS, Office of MaineCare Services Pharmacy Unit (MaineCare PDL, Optum) · Effective Oct 9, 2026 · read Nov 6, 2026
ZepboundNo
Listed only under sleep apnea. Requires moderate to severe sleep apnea confirmed by a sleep study, with prior authorization, BMI 30 or higher.
“diagnosis of moderate to severe OSA, confirmed by sleep study within the last 3 years”
Maine DHHS, Office of MaineCare Services Pharmacy Unit (MaineCare PDL, Optum) · Effective Oct 9, 2026 · read Nov 6, 2026
“Weight loss drugs are not covered as permitted by Federal Medicaid regulations and Maine Medicaid (MaineCare) Policy.”
Maine DHHS, Office of MaineCare Services Pharmacy Unit (MaineCare PDL, Optum) · Effective Oct 9, 2026 · read Nov 6, 2026
OzempicUnclear
The MaineCare PDL says weight loss drugs are not covered, but that general line does not name this drug and the PDL gives no drug-specific limit for it. Ozempic is listed under the diabetes incretin category.
“Weight loss drugs are not covered as permitted by Federal Medicaid regulations and Maine Medicaid (MaineCare) Policy.”
Maine DHHS, Office of MaineCare Services Pharmacy Unit (MaineCare PDL, Optum) · Effective Oct 9, 2026 · read Nov 6, 2026
MounjaroUnclear
The MaineCare PDL says weight loss drugs are not covered, but that general line does not name this drug and the PDL gives no drug-specific limit for it. Mounjaro is not on the 10/9/2026 PDL at all, though the 10/1/2025 PDL listed it as non-preferred.
“Weight loss drugs are not covered as permitted by Federal Medicaid regulations and Maine Medicaid (MaineCare) Policy.”
Maine DHHS, Office of MaineCare Services Pharmacy Unit (MaineCare PDL, Optum) · Effective Oct 9, 2026 · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Maine Department of Health and Human Services, Office of MaineCare Services documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
1,760 prescriptions
Ozempic and Mounjaro, 2025
13,687 prescriptions
Neighbours covering weight loss
0 of 3
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Maine Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Maine Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Maine Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Maine Medicaid pay for?
41,655 GLP-1 prescriptions in 2025, 39th of the 50 states and DC, with $38.9 million reimbursed before rebates. Counting the share other payers covered, $40.6 million.
Prescriptions, 2025
41,655
39th of 51
Medicaid paid
$38.9M
38th of 51, before rebates
Per prescription
$933
$1,051 nationally
Weight-loss brands
4.2%
26th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Maine is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 4.2% of Maine Medicaid's GLP-1 prescriptions in 2025 (1,760). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Trulicity was Maine Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Trulicity | 22,493 | 54% | $21.3 million | $949 |
| Ozempic | 9,109 | 22% | $8.4 million | $927 |
| Mounjaro | 4,578 | 11% | $4.4 million | $964 |
| Rybelsus | 2,292 | 5.5% | $2.2 million | $969 |
| Victoza | 1,034 | 2.5% | $657,094 | $635 |
| Wegovyapproved for weight management | 1,002 | 2.4% | $1.0 million | $1,022 |
| Zepboundapproved for weight management | 758 | 1.8% | $536,383 | $708 |
| Liraglutide (generic) | 348 | 0.8% | $203,934 | $586 |
| Bydureon | 41 | 0.1% | $33,028 | $806 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
On Medicare in Maine?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Maine and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
None of the 3 states next to Maine covers GLP-1s for weight loss through Medicaid. None has a lower cash floor than Maine's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Maine | Not covered | 19 | $39/mo |
| New Hampshire | Not covered | 19 | $39/moWellmedr |
| Vermont | Not covered | 19 | $39/moWellmedr |
| Massachusetts | Not covered | 18 | $39/moWellmedr |






















